BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34634556)

  • 1. pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment.
    Nunes SS; Miranda SEM; de Oliveira Silva J; Fernandes RS; de Alcântara Lemos J; de Aguiar Ferreira C; Townsend DM; Cassali GD; Oliveira MC; Branco de Barros AL
    Biomed Pharmacother; 2021 Dec; 144():112317. PubMed ID: 34634556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-pH Sensitive Charge-Reversal Drug Delivery System for Highly Precise and Penetrative Chemotherapy.
    Chen W; Li J; Xing Y; Wang X; Zhang H; Xia M; Wang D
    Pharm Res; 2020 Jul; 37(7):134. PubMed ID: 32642819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG-coated irinotecan cationic liposomes improve the therapeutic efficacy of breast cancer in animals.
    Zhang L; Cao DY; Wang J; Xiang B; Dun JN; Fang Y; Xue GQ
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3347-61. PubMed ID: 24379067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-Responsive PEG-Shedding and Targeting Peptide-Modified Nanoparticles for Dual-Delivery of Irinotecan and microRNA to Enhance Tumor-Specific Therapy.
    Juang V; Chang CH; Wang CS; Wang HE; Lo YL
    Small; 2019 Dec; 15(49):e1903296. PubMed ID: 31709707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan.
    Riviere K; Kieler-Ferguson HM; Jerger K; Szoka FC
    J Control Release; 2011 Aug; 153(3):288-96. PubMed ID: 21600250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity.
    Monteiro LOF; Fernandes RS; Castro L; Reis D; Cassali GD; Evangelista F; Loures C; Sabino AP; Cardoso V; Oliveira MC; Branco de Barros A; Leite EA
    Mol Pharm; 2019 Aug; 16(8):3477-3488. PubMed ID: 31257891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superparamagnetic chitosan nanocomplexes for colorectal tumor-targeted delivery of irinotecan.
    Wu D; Zhu L; Li Y; Wang H; Xu S; Zhang X; Wu R; Yang G
    Int J Pharm; 2020 Jun; 584():119394. PubMed ID: 32407940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral Injection Administration of Irinotecan-Loaded Microspheres: In Vitro and In Vivo Evaluation.
    Zhu S; Dou M; Huang G
    AAPS PharmSciTech; 2018 Nov; 19(8):3829-3838. PubMed ID: 30280351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
    Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model.
    de Oliveira Silva J; Fernandes RS; Ramos Oda CM; Ferreira TH; Machado Botelho AF; Martins Melo M; de Miranda MC; Assis Gomes D; Dantas Cassali G; Townsend DM; Rubello D; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2019 Oct; 118():109323. PubMed ID: 31400669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuning the pharmacokinetics and efficacy of irinotecan (IRI) loaded gelatin nanoparticles through folate conjugation.
    Das RP; Chakravarti S; Patel SS; Lakhamje P; Gurjar M; Gota V; Singh BG; Kunwar A
    Int J Pharm; 2020 Aug; 586():119522. PubMed ID: 32534159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Therapeutic Efficacy of Topotecan Against A549 Lung Cancer Cells with Folate-targeted Topotecan Liposomes.
    Zhang J; Shi W; Xue G; Ma Q; Cui H; Zhang L
    Curr Drug Metab; 2020; 21(11):902-909. PubMed ID: 32851958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer.
    Lo YL; Chang CH; Wang CS; Yang MH; Lin AM; Hong CJ; Tseng WH
    Theranostics; 2020; 10(15):6695-6714. PubMed ID: 32550898
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of liposomes entrapped in alginate beads for the treatment of colorectal cancer.
    Bansal D; Gulbake A; Tiwari J; Jain SK
    Int J Biol Macromol; 2016 Jan; 82():687-95. PubMed ID: 26464131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity.
    Shmeeda H; Amitay Y; Tzemach D; Gorin J; Gabizon A
    J Control Release; 2013 May; 167(3):265-75. PubMed ID: 23419948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?
    Abu Lila AS; Okada T; Doi Y; Ichihara M; Ishida T; Kiwada H
    Int J Pharm; 2012 Apr; 426(1-2):263-270. PubMed ID: 22310465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastoma.
    Verreault M; Wehbe M; Strutt D; Masin D; Anantha M; Walker D; Chu F; Backstrom I; Kalra J; Waterhouse D; Yapp DT; Bally MB
    J Control Release; 2015 Dec; 220(Pt A):348-357. PubMed ID: 26528901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction-responsive sulfur dioxide polymer prodrug nanoparticles loaded with irinotecan for combination osteosarcoma therapy.
    Li Y; Qu J; Zhang P; Zhang Z
    Nanotechnology; 2020 Nov; 31(45):455101. PubMed ID: 32688350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer.
    Gao J; Nesbitt H; Logan K; Burnett K; White B; Jack IG; Taylor MA; Love M; Callan B; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2020 Dec; 157():233-240. PubMed ID: 33222772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of trapping agents on the antitumor efficacy of irinotecan liposomes: head-to-head comparison of ammonium sulfate, sulfobutylether-β-cyclodextrin and sucrose octasulfate.
    Yang W; Yang Z; Fu J; Guo M; Sun B; Wei W; Liu D; Liu H
    Biomater Sci; 2018 Dec; 7(1):419-428. PubMed ID: 30500018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.